PEStore

Growth Equity

K2 HealthVentures

K2 HealthVentures takes minority stakes in growing companies, usually without full control, from United States. It states a focus on healthcare & life sciences.

Disclosed holdings46
Earliest stated investment
HeadquartersUnited States
Stated fund size$1 Bn+

Stated investment criteria

What K2 HealthVentures says it buys

Read from K2 HealthVentures’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

People listed on its team page201

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by K2 HealthVentures to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies K2 HealthVentures lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
89bio
89bio (NASDAQ: ETNB)
89bio Wjnfs
89bio Wjnfs Tmw2b Wy5kk
89bio Wjnfs Tmw2b Wy5kk Bbap2
89bio Wjnfs Tmw2b Wy5kk Bbap2 Y2fxd Xeftg
89bio Wjnfs Tmw2b Wy5kk Bbap2 Y2fxd Xeftg Dzg7p
Acumen Pharmaceuticals (NASDAQ: ABOS)
Alignment Health
Alignment Health (NASDAQ: ALHC)
Alto Neuroscience
Alto Neuroscience (NYSE: ANRO)
Apella
Cartesian
Cartesian Therapeutics
Concert
Concert Health
Evergreen
Evergreen Nephrology
Fuze Health
Gravie
HarmonyCares
Honest Health
Infusion for Health
Kandu Health
Longevity
Mighty
Mighty Therapeutics
MindMed (NASDAQ: MNMD)
Neumora
Neumora Therapeutics
OncXerna Therapeutics
Orthofix
Phil
Sidecar
Sidecar Health
Spark Pediatrics
Suvida
Suvida Healthcare
Theragen
Umoja
Umoja Biopharma
Vedanta Biosciences
Werewolftx
Zarminali
Zarminali Pediatrics

Compiled from K2 HealthVentures’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this K2 HealthVentures?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other growth equity investors active in healthcare & life sciences.